Breakdown | |||||
TTM | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 |
---|---|---|---|---|---|
Income Statement | Total Revenue | ||||
370.99M | 306.62M | 204.50M | 151.98M | 107.52M | 76.43M | Gross Profit |
101.06M | 57.23M | 9.07M | -42.74M | 17.14M | -231.00K | EBIT |
-115.11M | -108.68M | -159.95M | -194.06M | -29.11M | -53.86M | EBITDA |
-74.58M | -80.85M | -132.26M | -180.36M | -11.09M | -38.81M | Net Income Common Stockholders |
-114.56M | -106.34M | -158.20M | -211.49M | -33.63M | -59.66M |
Balance Sheet | Cash, Cash Equivalents and Short-Term Investments | ||||
809.14K | 51.13M | 256.49M | 480.93M | 21.50M | 140.30K | Total Assets |
277.26M | 1.10B | 984.96M | 995.29M | 404.51M | 280.50M | Total Debt |
0.00 | 202.77M | 173.07M | 147.40M | 151.03M | 150.15M | Net Debt |
-809.14K | 158.23M | -58.35M | -333.53M | 129.53M | 150.01M | Total Liabilities |
141.27K | 532.54M | 371.98M | 308.59M | 698.29M | 296.12K | Stockholders Equity |
277.12M | 564.19M | 612.98M | 686.70M | -384.60M | 280.20M |
Cash Flow | Free Cash Flow | ||||
-77.81M | -262.09M | -204.81M | -132.90M | -3.09M | -6.89M | Operating Cash Flow |
-23.31M | -75.30M | -53.93M | -45.04M | 15.56M | 13.37M | Investing Cash Flow |
-24.46M | -165.60M | -175.94M | -87.86M | -17.67M | -3.95M | Financing Cash Flow |
82.60M | 29.53M | 4.97M | 624.95M | -507.00K | -52.18M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
62 Neutral | $8.05B | 13.61 | 3.91% | 3.08% | 3.83% | -13.91% | |
61 Neutral | $388.67M | ― | -21.32% | ― | 39.03% | 2.67% | |
59 Neutral | $182.64M | ― | -26.15% | ― | ― | -457.87% | |
52 Neutral | $202.01M | ― | -21.13% | ― | 15.67% | -45.59% | |
46 Neutral | $2.47B | ― | -38.29% | ― | ― | 2.40% | |
44 Neutral | $1.43B | ― | -88.04% | ― | 1429.35% | -36.13% | |
39 Underperform | $2.09M | ― | -274.78% | ― | -33.71% | -311.25% |
Microvast Holdings, Inc. announced the resignation of Lu Gao as Chief Accounting Officer for personal reasons, with no disagreements over company policies. The company also approved executive compensation adjustments, including salary increases, cash bonuses, and equity awards for key executives like Yang Wu, Isida Tushe, and Dr. Shengxian Wu to acknowledge their added responsibilities. This move reflects the company’s commitment to retaining leadership talent amidst ongoing operational demands.